Metabolic engineering for production of small molecule drugs: Challenges and solutions

Fermentation

Volumn 2, Issue 1, 2016, Pages

  Huttanus, Herbert M ^a   Sheng, Jiayuan ^a   Feng, Xueyang ^a  

^a State University   (United States)

Author keywords

Metabolic engineering; Pathway assembly; Pathway discovery; Pathway optimization

Indexed keywords

EID: 85032587201     PISSN: None     EISSN: 23115637     Source Type: Journal    
DOI: 10.3390/fermentation2010004     Document Type: Review

References (107)

1. Schreiber, S.L.; Halpern, J. Organic synthesis toward small-molecule probes and drugs. Proc. Natl. Acad. Sci. USA 2011, 108, 6699–6702. [CrossRef] [PubMed]
2. Winter, J.M.; Behnken, S.; Hertweck, C. Genomics-inspired discovery of natural products. Curr. Opin. Chem. Biol. 2011, 15, 22–31. [CrossRef] [PubMed]
3. Newman, D.J. Natural products as leads to potential drugs: An old process or the new hope for drug discovery? J. Med. Chem. 2008, 51, 2589–2599. [CrossRef] [PubMed]
4. Galm, U.; Shen, B. Expression of biosynthetic gene clusters in heterologous hosts for natural product production and combinatorial biosynthesis. Expert Opin. Drug Discov. 2006, 1, 409–437. [CrossRef] [PubMed]
5. Luo, Y.; Li, B.-Z.; Liu, D.; Zhang, L.; Chen, Y.; Jia, B.; Zeng, B.-X.; Zhao, H.; Yuan, Y.-J. Engineered biosynthesis of natural products in heterologous hosts. Chem. Soc. Rev. 2015, 44, 5265–5290. [CrossRef] [PubMed]
6. Winter, J.M.; Tang, Y. Synthetic biological approaches to natural product biosynthesis. Curr. Opin. Biotechnol. 2012, 23, 736–743. [CrossRef] [PubMed]
7. Zadran, S.; Levine, R.D. Perspectives in metabolic engineering: Understanding cellular regulation towards the control of metabolic routes. Appl. Biochem. Biotechnol. 2013, 169, 55–65. [CrossRef] [PubMed]
8. Ho, K.A.; Keasling, J.D.; Kirby, J.; Shiba, Y.; Paradise, E.M.; Fisher, K.J.; Ro, D.-K.; Ndungu, J.M.; Chang, M.C.Y.; Newman, K.L.; et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440, 940–943.
9. Thodey, K.; Galanie, S.; Smolke, C.D. A microbial biomanufacturing platform for natural and semisynthetic opioids. Nat. Chem. Biol. 2014, 10, 837–844. [CrossRef] [PubMed]
10. Ajikumar, P.K.; Xiao, W.-H.; Keith, E.J.T.; Wang, Y.; Simeon, F.; Leonard, E.; Mucha, O.; Phon, T.H.; Pfeifer, B.; Stephanopoulos, G. Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli. Science 2010, 330, 70–74. [CrossRef] [PubMed]
11. Cobb, R.E.; Zhao, H.M. Direct cloning of large genomic sequences. Nat. Biotechnol. 2012, 30, 405–406. [CrossRef] [PubMed]
12. Guerra-Bubb, J.; Croteau, R.; Williams, R.M. The early stages of taxol biosynthesis: An interim report on the synthesis and identification of early pathway metabolites. Nat. Prod. Rep. 2012, 29, 683–696. [CrossRef] [PubMed]
13. Piškur, J.; Schnackerz, K.D.; Andersen, G.; Björnberg, O. Comparative genomics reveals novel biochemical pathways. Trends Genet. 2007, 23, 369–372. [CrossRef] [PubMed]
14. Dellas, N.; Thomas, S.T.; Manning, G.; Noel, J.P. Discovery of a metabolic alternative to the classical mevalonate pathway. ELIFE 2013, 2, e00672. [CrossRef] [PubMed]
15. Alexander, R.W. Teasing apart the Taxol pathway. Trends Biochem. Sci. 2001, 26, 152–153. [CrossRef]
16. Sato, M.; Yamada, H.; Hotta, K.; Watanabe, K. Elucidation of the shanorellin biosynthetic pathway and functional analysis of associated enzymes. Medchemcomm 2015, 6, 425–430. [CrossRef]
17. Tang, Y.J.; Martin, H.G.; Myers, S.; Rodriguez, S.; Baidoo, E.E.; Keasling, J.D. Advances in analysis of microbial metabolic fluxes via (13)C isotopic labeling. Mass Spectrom. Rev. 2009, 28, 362–375. [CrossRef] [PubMed]
18. Sulikowski, G.A.; Pongdee, R. Elucidation of the Biosynthetic Pathway Leading to the Complex Nonadride Phomoidride B. Synlett 2006, 2006, 354–363. [CrossRef]
19. Nonaka, K.; Ahlert, J.; Thorson, J.S.; Bachmann, B.O.; Zazopoulos, E.; Shen, B.; Huang, K.; Staffa, A.; Liu, W.; Farnet, C.M. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat. Biotechnol. 2003, 21, 187–190.
20. Mattheus, W.; Gao, L.-J.; Herdewijn, P.; Landuyt, B.; Verhaegen, J.; Masschelein, J.; Volckaert, G.; Lavigne, R. Isolation and Purification of a New Kalimantacin/Batumin-Related Polyketide Antibiotic and Elucidation of Its Biosynthesis Gene Cluster. Chem. Biol. 2010, 17, 149–159. [CrossRef] [PubMed]
21. Gross, H.; Stockwell, V.O.; Henkels, M.D.; Nowak-Thompson, B.; Loper, J.E.; Gerwick, W.H. The Genomisotopic Approach: A Systematic Method to Isolate Products of Orphan Biosynthetic Gene Clusters. Chem. Biol. 2007, 14, 53–63. [CrossRef] [PubMed]
22. Yang, Y.F.; Zhao, H.N.; Barrero, R.A.; Zhang, B.H.; Sun, G.L.; Wilson, I.W.; Xie, F.L.; Walker, K.D.; Parks, J.W.; Bruce, R.; et al. Genome sequencing and analysis of the paclitaxel-producing endophytic fungus Penicillium aurantiogriseum NRRL 62431. BMC Genom. 2014, 15, 69. [CrossRef] [PubMed]
23. Zhao, W.; Zhong, Y.; Yuan, H.; Wang, J.; Zheng, H.; Wang, Y.; Cen, X.; Xu, F.; Bai, J.; Han, X.; et al. Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell Res. 2010, 20, 1096–1108. [CrossRef] [PubMed]
24. Hagel, J.M.; Facchini, P.J. Dioxygenases catalyze the O-demethylation steps of morphine biosynthesis in opium poppy. Nat. Chem. Biol. 2010, 6, 273–275. [CrossRef] [PubMed]
25. Hao, D.C.; Ge, G.B.; Xiao, P.G.; Zhang, Y.Y.; Yang, L. The First Insight into the Tissue Specific Taxus Transcriptome via Illumina Second Generation Sequencing. PLoS ONE 2011, 6, e21220. [CrossRef] [PubMed]
26. Ziemert, N.; Ishida, K.; Liaimer, A.; Hertweck, C.; Dittmann, E. Ribosomal synthesis of tricyclic depsipeptides in bloom-forming cyanobacteria. Angew. Chem. 2008, 47, 7756–7759. [CrossRef] [PubMed]
27. Yamanaka, K.; Reynolds, K.A.; Kersten, R.D.; Ryan, K.S.; Gonzalez, D.J.; Nizet, V.; Dorrestein, P.C.; Moore, B.S. Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc. Natl. Acad. Sci. 2014, 111, 1957–1962. [CrossRef] [PubMed]
28. Chatterjee, R.; Yuan, L. Directed evolution of metabolic pathways. Trends Biotechnol. 2006, 24, 28–38. [CrossRef] [PubMed]
29. Brakhage, A.A.; Schuemann, J.; Bergmann, S.; Scherlach, K.; Schroeckh, V.; Hertweck, C. Activation of fungal silent gene clusters: A new avenue to drug discovery. Prog. Res. Fortschr. Arzneim. Prog. Rech. Pharm. 2008, 66, 1–12.
30. Yaegashi, J.; Oakley, B.R.; Wang, C.C.C. Recent advances in genome mining of secondary metabolite biosynthetic gene clusters and the development of heterologous expression systems in Aspergillus nidulans. J. Ind. Microbiol. Biotechnol. 2014, 41, 433–442. [CrossRef] [PubMed]
31. Chiang, Y.M.; Szewczyk, E.; Davidson, A.D.; Keller, N.; Oakley, B.R.; Wang, C.C.C. A Gene Cluster Containing Two Fungal Polyketide Synthases Encodes the Biosynthetic Pathway for a Polyketide, Asperfuranone, in Aspergillus nidulans. J. Am. Chem. Soc. 2009, 131, 2965–2970. [CrossRef] [PubMed]
32. Chiang, Y.-M.; Lo, H.-C.; Strauss, J.; Wang, C.C.C.; Davidson, A.D.; Oakley, B.R.; Reyes-Dominguez, Y.; Watanabe, K.; Szewczyk, E.; Sanchez, J.F.; et al. Chromatin-level regulation of biosynthetic gene clusters. Nat. Chem. Biol. 2009, 5, 462–464.
33. Moody, S.C. Microbial co-culture: Harnessing intermicrobial signaling for the production of novel antimicrobials. Fut. Microbiol. 2014, 9, 575–578. [CrossRef] [PubMed]
34. Brasch, J.; Horter, F.; Fritsch, D.; Beck-Jendroschek, V.; Tröger, A.; Francke, W. Acyclic sesquiterpenes released by Candida albicans inhibit growth of dermatophytes. Med. Mycol. 2014, 52, 46–55. [PubMed]
35. Dashti, Y.; Grkovic, T.; Abdelmohsen, U.R.; Hentschel, U.; Quinn, R.J. Production of Induced Secondary Metabolites by a Co-Culture of Sponge-Associated Actinomycetes, Actinokineospora sp. EG49 and Nocardiopsis sp. RV163. Mar. Drugs 2014, 12, 3046–3059. [CrossRef] [PubMed]
36. Luo, Y.; Huang, H.; Liang, J.; Wang, M.; Lu, L.; Shao, Z.; Cobb, R.E.; Zhao, H. Activation and characterization of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster. Nat. Commun. 2013, 4, 2894. [CrossRef] [PubMed]
37. Guo, Z.-R. Modification of natural products for drug discovery. Acta Pharm. Sin. 2012, 47, 144–157.
38. Chen, J.C.; Li, W.L.; Yao, H.Q.; Xu, J.Y. Insights into drug discovery from natural products through structural modification. Fitoterapia 2015, 103, 231–241. [CrossRef] [PubMed]
39. Nobili, S.; Landini, I.; Mazzei, T.; Mini, E. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Med. Res. Rev. 2012, 32, 1220–1262. [CrossRef] [PubMed]
40. Xu, J.; Yang, J.; Ran, Q.; Wang, L.; Wang, Z.; Liu, J.; Wu, X.; Hua, W.; Yuan, S.; Zhang, L.; et al. Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates. Bioorg. Med. Chem. Lett. 2008, 18, 4741–4744. [CrossRef] [PubMed]
41. Boehm, M.; Fuenfschilling, P.C.; Krieger, M.; Kuesters, E.; Struber, F. An improved manufacturing process for the antimalaria drug coartem. Part I. Org. Process Res. Dev. 2007, 11, 336–340. [CrossRef]
42. Westfall, P.J.; Pitera, D.J.; Lenihan, J.R.; Eng, D.; Woolard, F.X.; Regentin, R.; Horning, T.; Tsuruta, H.; Melis, D.J.; Owens, A.; et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl. Acad. Sci. USA 2012, 109, E111–E118. [CrossRef] [PubMed]
43. Wei, X.; Liang, D.; Ning, M.; Wang, Q.; Meng, X.; Li, Z. Semi-synthesis of neomangiferin from mangiferin. Tetrahedron Lett. 2014, 55, 3083–3086. [CrossRef]
44. Kong, J.; Yang, Y.; Wang, W.; Cheng, K.; Zhu, P. Artemisinic acid: A promising molecule potentially suitable for the semi-synthesis of artemisinin. RSC Adv. 2013, 3, 7622–7641. [CrossRef]
45. Moura, M.; Broadbelt, L.; Tyo, K. Computational tools for guided discovery and engineering of metabolic pathways. Methods Mol. Biol. 2013, 985, 123–147. [PubMed]
46. Brunk, E.; Neri, M.; Tavernelli, I.; Hatzimanikatis, V.; Rothlisberger, U. Integrating computational methods to retrofit enzymes to synthetic pathways. Biotechnol. Bioeng. 2012, 109, 572–582. [CrossRef] [PubMed]
47. Pleiss, J. Protein design in metabolic engineering and synthetic biology. Curr. Opin. Biotechnol. 2011, 22, 611–617. [CrossRef] [PubMed]
48. Kushnir, S.; Sundermann, U.; Yahiaoui, S.; Brockmeyer, A.; Janning, P.; Schulz, F. Minimally Invasive Mutagenesis Gives Rise to a Biosynthetic Polyketide Library. Angew. Chem. Int. Ed. 2012, 51, 10664–10669. [CrossRef] [PubMed]
49. Savile, C.K.; Janey, J.M.; Mundorff, E.C.; Moore, J.C.; Tam, S.; Jarvis, W.R.; Colbeck, J.C.; Krebber, A.; Fleitz, F.J.; Brands, J.; et al. Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture. Science 2010, 329, 305–309. [CrossRef] [PubMed]
50. Evans, B.S.; Chen, Y.; Metcalf, W.W.; Zhao, H.; Kelleher, N.L. Directed Evolution of the Nonribosomal Peptide Synthetase AdmK Generates New Andrimid Derivatives In Vivo. Chem. Biol. 2011, 18, 601–607. [CrossRef] [PubMed]
51. Sun, H.; Liu, Z.; Zhao, H.; El, A. Recent advances in combinatorial biosynthesis for drug discovery. Drug Des. Dev Ther. 2015, 2015, 823–833.
52. Liu, T.; Chiang, Y.M.; Somoza, A.D.; Oakley, B.R.; Wang, C.C.C. Engineering of an “Unnatural” Natural Product by Swapping Polyketide Synthase Domains in Aspergillus nidulans. J. Am. Chem. Soc. 2011, 133, 13314–13316. [CrossRef] [PubMed]
53. Galanie, S.; Thodey, K.; Trenchard, I.J.; Interrante, M.F.; Smolke, C.D. Complete biosynthesis of opioids in yeast. Science 2015, 349, 1095–1100. [CrossRef] [PubMed]
54. Zhou, K.; Qiao, K.; Edgar, S.; Stephanopoulos, G. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nat. Biotechnol. 2015, 33, 377–383. [CrossRef] [PubMed]
55. Jones, A.C.; Gust, B.; Kulik, A.; Heide, L.; Buttner, M.J.; Bibb, M.J. Phage P1-Derived Artificial Chromosomes Facilitate Heterologous Expression of the FK506 Gene Cluster. PLoS ONE 2013, 8, e69319. [CrossRef] [PubMed]
56. Tang, L.; Shah, S.; Chung, L.; Carney, J.; Katz, L.; Khosla, C.; Julien, B. Cloning and Heterologous Expression of the Epothilone Gene Cluster. Science 2000, 287, 640–642. [CrossRef] [PubMed]
57. Engler, C.; Gruetzner, R.; Kandzia, R.; Marillonnet, S. Golden Gate Shuffling: A One-Pot DNA Shuffling Method Based on Type IIs Restriction Enzymes. PLoS ONE 2009, 4, e5553. [CrossRef] [PubMed]
58. Bruckner, K.; Tissier, A. High-level diterpene production by transient expression in Nicotiana benthamiana. Plant Methods 2013, 9, 46. [CrossRef] [PubMed]
59. Shao, Z.; Zhao, H. DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res. 2009, 37, e16. [CrossRef] [PubMed]
60. Fossati, E.; Narcross, L.; Ekins, A.; Falgueyret, J.P.; Martin, V.J.J. Synthesis of Morphinan Alkaloids in Saccharomyces cerevisiae. PLoS ONE 2015, 10, e0124459. [CrossRef] [PubMed]
61. Wenzel, S.C.; Gross, F.; Zhang, Y.; Fu, J.; Stewart, A.F.; Müller, R. Heterologous Expression of a Myxobacterial Natural Products Assembly Line in Pseudomonads via Red/ET Recombineering. Chem. Biol. 2005, 12, 349–356. [CrossRef] [PubMed]
62. Cobb, R.E.; Ning, J.C.; Zhao, H. DNA assembly techniques for next-generation combinatorial biosynthesis of natural products. J. Ind. Microbiol. Biotechnol. 2014, 41, 469–477. [CrossRef] [PubMed]
63. Tokmakov, A.A.; Kurotani, A.; Takagi, T.; Toyama, M.; Shirouzu, M.; Fukami, Y.; Yokoyama, S. Multiple Post-translational Modifications Affect Heterologous Protein Synthesis. J. Biol. Chem. 2012, 287, 27106–27116. [CrossRef] [PubMed]
64. Gustafsson, C.; Govindarajan, S.; Minshull, J. Codon bias and heterologous protein expression. Trends Biotechnol. 2004, 22, 346–353. [CrossRef] [PubMed]
65. Bernaudat, F.; Frelet-Barrand, A.; Pochon, N.; Dementin, S.; Hivin, P.; Boutigny, S.; Rioux, J.B.; Salvi, D.; Seigneurin-Berny, D.; Richaud, P.; et al. Heterologous Expression of Membrane Proteins: Choosing the Appropriate Host. PLoS ONE 2011, 6, e29191. [CrossRef] [PubMed]
66. Thanapipatsiri, A.; Claesen, J.; Gomez-Escribano, J.P.; Bibb, M.; Thamchaipenet, A. A Streptomyces coelicolor host for the heterologous expression of Type III polyketide synthase genes. Microb. Cell Factories 2015, 14, 145. [CrossRef] [PubMed]
67. Condon, A.; Thachuk, C. Efficient codon optimization with motif engineering. J. Discret. Algorithms 2012, 16, 104. [CrossRef]
68. Gvritishvili, A.G.; Leung, K.W.; Tombran-Tink, J. Codon Preference Optimization Increases Heterologous PEDF Expression. PLoS ONE 2010, 5, e15056. [CrossRef] [PubMed]
69. Lee, N.; Lee, S.-H.; Baek, K.; Kim, B.-G. Heterologous expression of tyrosinase (MelC2) from Streptomyces avermitilis MA4680 in E. coli and its application for ortho-hydroxylation of resveratrol to produce piceatannol. Appl. Microbiol. Biotechnol. 2015, 99, 7915–7924. [CrossRef] [PubMed]
70. Okesli, A.; Cooper, L.E.; Fogle, E.J.; van der Donk, W.A. Nine Post-translational Modifications during the Biosynthesis of Cinnamycin. J. Am. Chem. Soc. 2011, 133, 13753–13760. [CrossRef] [PubMed]
71. Pfeifer, B.A.; Admiraal, S.J.; Gramajo, H.; Cane, D.E.; Khosla, C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 2001, 291, 1790–1792. [CrossRef] [PubMed]
72. DeLoache, W.C.; Russ, Z.N.; Narcross, L.; Gonzales, A.M.; Martin, V.J.; Dueber, J.E. An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. Nat. Chem. Biol. 2015, 11, 465–471. [CrossRef] [PubMed]
73. Zou, X.; Li, J. Precursor engineering and cell physiological regulation for high level rapamycin production by Streptomyces hygroscopicus. Ann. Microbiol. 2013, 63, 1371–1378. [CrossRef]
74. Ryu, Y.G.; Butler, M.J.; Chater, K.F.; Lee, K.J. Engineering of primary carbohydrate metabolism for increased production of actinorhodin in Streptomyces coelicolor. Appl. Environ. Microbiol. 2006, 72, 7132–7139. [CrossRef] [PubMed]
75. Huang, D.; Xia, M.; Li, S.; Wen, J.; Jia, X. Enhancement of FK506 production by engineering secondary pathways of Streptomyces tsukubaensis and exogenous feeding strategies. J. Ind. Microbiol. Biotechnol. 2013, 40, 1023–1037. [CrossRef] [PubMed]
76. 13 C-metabolic flux analysis of a xylose-consuming Saccharomyces cerevisiae strain expressing xylose isomerase. Biotechnol. Bioeng. 2015, 112, 470–483. [CrossRef] [PubMed]
77. 13 C-based metabolism analysis. Microb. Cell Factor. 2014, 13, 42. [CrossRef] [PubMed]
78. 13 C-based metabolic flux analysis. Nat. Protoc. 2009, 4, 878–892. [CrossRef] [PubMed]
79. Feng, X.; Page, L.; Rubens, J.; Chircus, L.; Colletti, P.; Pakrasi, H.B.; Tang, Y.J. Bridging the gap between fluxomics and industrial biotechnology. J. Biomed. Biotechnol. 2010, 2010, 460717. [CrossRef] [PubMed]
80. Huang, D.; Jia, X.; Wen, J.; Wang, G.; Yu, G.; Caiyin, Q.; Chen, Y. Metabolic Flux Analysis and Principal Nodes Identification for Daptomycin Production Improvement by Streptomyces roseosporus. Appl. Biochem. Biotechnol. 2011, 165, 1725–1739. [CrossRef] [PubMed]
81. Liu, C.-J.; Blount, J.W.; Steele, C.L.; Dixon, R.A. Bottlenecks for Metabolic Engineering of Isoflavone Glycoconjugates in Arabidopsis. Proc. Natl. Acad. Sci. USA 2002, 99, 14578–14583. [CrossRef] [PubMed]
82. Cluis, C.P.; Ekins, A.; Narcross, L.; Jiang, H.; Gold, N.D.; Burja, A.M.; Martin, V.J.J. Identification of bottlenecks in Escherichia coli engineered for the production of CoQ(10). Metabol. Eng. 2011, 13, 733–744. [CrossRef] [PubMed]
83. Rodrigues, A.L.; Becker, J.; de Souza Lima, A.O.; Porto, L.M.; Wittmann, C. Systems metabolic engineering of Escherichia coli for gram scale production of the antitumor drug deoxyviolacein from glycerol. Biotechnol. Bioeng. 2014, 111, 2280–2289. [CrossRef] [PubMed]
84. Guo, J.; Zhao, J.; Li, L.; Chen, Z.; Wen, Y.; Li, J. The pathway-specific regulator AveR from Streptomyces avermitilis positively regulates avermectin production while it negatively affects oligomycin biosynthesis. Mol. Genet. Genom. 2010, 283, 123–133. [CrossRef] [PubMed]
85. Venayak, N.; Anesiadis, N.; Cluett, W.R.; Mahadevan, R. Engineering metabolism through dynamic control. Curr. Opin. Biotechnol. 2015, 34, 142–152. [CrossRef] [PubMed]
86. Alper, H.; Fischer, C.; Nevoigt, E.; Stephanopoulos, G.; Langer, R. Tuning Genetic Control through Promoter Engineering. Proc. Natl. Acad. Sci. USA 2005, 102, 12678–12683. [CrossRef] [PubMed]
87. Zhang, F.Z.; Carothers, J.M.; Keasling, J.D. Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids. Nat. Biotechnol. 2012, 30, 354–359. [CrossRef] [PubMed]
88. Williams, T.C.; Averesch, N.J.H.; Winter, G.; Plan, M.R.; Vickers, C.E.; Nielsen, L.K.; Krömer, J.O. Quorum-sensing linked RNA interference for dynamic metabolic pathway control in Saccharomyces cerevisiae. Metab. Eng. 2015, 29, 124–134. [CrossRef] [PubMed]
89. Dahl, R.H.; Zhang, F.; Alonso-Gutierrez, J.; Baidoo, E.; Batth, T.S.; Redding-Johanson, A.M.; Petzold, C.J.; Mukhopadhyay, A.; Lee, T.S.; Adams, P.D.; et al. Engineering dynamic pathway regulation using stress-response promoters. Nat. Biotechnol. 2013, 31, 1039–1046. [CrossRef] [PubMed]
90. Eckdahl, T.T.; Campbell, A.M.; Heyer, L.J.; Poet, J.L.; Blauch, D.N.; Snyder, N.L.; Atchley, D.T.; Baker, E.J.; Brown, M.; Brunner, E.C.; et al. Programmed Evolution for Optimization of Orthogonal Metabolic Output in Bacteria. PLoS ONE 2015, 10, e0118322. [CrossRef] [PubMed]
91. Skretas, G.; Kolisis, F.N. Combinatorial approaches for inverse metabolic engineering applications. Comput. Struct. Biotechnol. J. 2012, 3, e201210021. [CrossRef] [PubMed]
92. Dudley, Q.M.; Karim, A.S.; Jewett, M.C. Cell-free metabolic engineering: Biomanufacturing beyond the cell. Biotechnol. J. 2015, 10, 69–82. [CrossRef] [PubMed]
93. Go, Y.-M.; Jones, D.P. Redox compartmentalization in eukaryotic cells. BBA Gen. Subj. 2008, 1780, 1273–1290. [CrossRef] [PubMed]
94. Chen, A.H.; Silver, P.A. Designing biological compartmentalization. Trends Cell Biol. 2012, 22, 662–670. [CrossRef] [PubMed]
95. Saxena, B.; Subramaniyan, M.; Malhotra, K.; Bhavesh, N.S.; Potlakayala, S.D.; Kumar, S. Metabolic engineering of chloroplasts for artemisinic acid biosynthesis and impact on plant growth. J. Biosci. 2014, 39, 33–41. [CrossRef] [PubMed]
96. Herr, A.; Fischer, R. Improvement of Aspergillus nidulans penicillin production by targeting AcvA to peroxisomes. Metab. Eng. 2014, 25, 131–139. [CrossRef] [PubMed]
97. Farhi, M.; Marhevka, E.; Masci, T.; Marcos, E.; Eyal, Y.; Ovadis, M.; Abeliovich, H.; Vainstein, A. Harnessing yeast subcellular compartments for the production of plant terpenoids. Metab. Eng. 2011, 13, 474–481. [CrossRef] [PubMed]
98. Choudhary, S.; Quin, M.B.; Sanders, M.A.; Johnson, E.T.; Schmidt-Dannert, C. Engineered protein nano-compartments for targeted enzyme localization. PLoS ONE 2012, 7, e33342. [CrossRef] [PubMed]
99. Wu, G.C.; Prather, K.L.J.; Malmirchegini, G.R.; Petzold, C.J.; Ullal, A.V.; Dueber, J.E.; Moon, T.S.; Keasling, J.D. Synthetic protein scaffolds provide modular control over metabolic flux. Nat. Biotechnol. 2009, 27, 753–759.
100. Zhou, Y.J.; Gao, W.; Rong, Q.X.; Jin, G.J.; Chu, H.Y.; Liu, W.J.; Yang, W.; Zhu, Z.W.; Li, G.H.; Zhu, G.F.; et al. Modular Pathway Engineering of Diterpenoid Synthases and the Mevalonic Acid Pathway for Miltiradiene Production. J. Am. Chem. Soc. 2012, 134, 3234–3241. [CrossRef] [PubMed]
101. Wang, J.-F.; Xiong, Z.-Q.; Li, S.-Y.; Wang, Y. Enhancing isoprenoid production through systematically assembling and modulating efflux pumps in Escherichia coli. Appl. Microbiol. Biotechnol. 2013, 97, 8057–8067. [CrossRef] [PubMed]
102. Meng, C.; Kuster, B.; Culhane, A.C.; Gholami, A.M. A multivariate approach to the integration of multi-omics datasets. BMC Bioinform. 2014, 15, 162. [CrossRef] [PubMed]
103. Cong, L.; Ran, F.A.; Cox, D.; Lin, S.; Barretto, R.; Habib, N.; Hsu, P.D.; Wu, X.; Jiang, W.; Marraffini, L.A.; et al. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science 2013, 339, 819–823. [CrossRef] [PubMed]
104. Yadav, V.G.; de Mey, M.; Lim, C.G.; Ajikumar, P.K.; Stephanopoulos, G. The future of metabolic engineering and synthetic biology: Towards a systematic practice. Metab. Eng. 2012, 14, 233–241. [CrossRef] [PubMed]
105. Zalatan, J.G.; Lee, M.E.; Almeida, R.; Gilbert, L.A.; Whitehead, E.H.; La Russa, M.; Tsai, J.C.; Weissman, J.S.; Dueber, J.E.; Qi, L.S.; et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 2015, 160, 339–350. [CrossRef] [PubMed]
106. Xu, P.; Li, L.; Zhang, F.; Stephanopoulos, G.; Koffas, M. Improving fatty acids production by engineering dynamic pathway regulation and metabolic control. Proc. Natl. Acad. Sci. USA 2014, 111, 11299–11304. [CrossRef] [PubMed]
107. Sparkman-Yager, D.; Correa-Rojas, R.A.; Carothers, J.M. Kinetic folding design of aptazyme-regulated expression devices as riboswitches for metabolic engineering. Methods Enzymol. 2015, 550, 321. [PubMed]